Advertisement

Topics

Companies Related to "Positron Emission Tomography (PET) to Study Brain Signaling" [Most Relevant Company Matches] - Page: 20 RSS

12:24 EDT 24th March 2019 | BioPortfolio

Here are the most relevant search results for "Positron Emission Tomography (PET) to Study Brain Signaling" found in our extensive corporate database of over 50,000 company records.

Showing "Positron Emission Tomography Study Brain Signaling" Companies 476–500 of 1,100+

Probably Relevant

Panagin Pharmaceuticals Inc.

Panagin Pharmaceuticals Inc., a privately-held biotech company, specializes in the discovery, research, development and commercialization of saponin based anti-cancer drugs. Panagin's proprietary new drug candidates show strong anti-cancer properties against various advanced, metastatic, multi-drug resistant cancers. Panagin's research and clinical programs focus on life-threatening diseases, such...


Kinetic Muscles Inc.

Founded in 2001 in Tempe, AZ, KMI addresses the rehab therapy needs of patients suffering from stroke, traumatic brain injury (TBI), multiple sclerosis, incomplete spinal cord injury, and cerebral palsy. KMI is a thought leader in the field providing solutions that merge digital and robotic technologies with sound neurotherapy principles to deliver ‘Improved...

Dynawell International AG

DynaWellTM is a privately owned Sweden based medical technology company founded in 1998.Our mission is to assist medical professionals by offering sophisticated diagnostic techniques for CT and MRI scanners. This provides a more accurate diagnosis to enhance the possibility of optimal and cost-effective treatment. Ultimately, we strive to help people who are experiencing pain or discomfort to retu...


Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc. (OTCBB: BZYR) is a biopharmaceutical company committed to developing treatment for cancer based on genomic and epigenomic principles. Research and development efforts are focused on basic research and phase 3 clinical trials, particularly in the treatment of brain tumors and other forms of cancer.

Weill Cornell Medical College

Weill Cornell Medical College, Cornell University's medical school located in New York City, is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine, locally, nationally and globally. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research from bench to bedside, aimed at unlocking mysteries ...

Elekta

Elekta is a human-care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment-planning systems for radiation therapy and radiosurgery, as well as workflow-enhancing software systems across the spectrum of cancer care.

Lingraphica

Founded in 1991 and based in Princeton, N.J., Lingraphica is a healthcare technology firm whose mission is to provide the technology, support and resources that offer hope for adults with aphasia and verbal apraxia who lost their ability to speak, write or read following a stroke or traumatic brain injury and empower them to improve their lives. For more i...

AOBiome

AOBiome LLC is developing a transformative, new class of products based on Ammonia Oxidizing Bacteria (AOB) to improve skin health and prevent or treat skin and inflammatory diseases. The company’s probiotics are designed to provide cosmetic and therapeutic benefits by restoring the natural, protective balance afforded by beneficial skin microbes that ...

CMS Software

CMS Software is part of the Elekta Group, a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Pamlab

Deplin is a prescription medical food for the dietary management of suboptimal L-methylfolate levels in patients with depression. Up to 70 percent of people who suffer from depression may have a specific genetic factor that compromises their ability to convert folic acid into L-methylfolate. L-methylfolate is the only form of folate that can cross the blood brain barrier and regulate serotonin, ...

VasSol Inc.

VasSol Inc. is a privately owned medical technology company based in River Forest, Ill. It was founded in 2001 by Dr. Fady Charbel, neurosurgeon and inventor of NOVA, the only technology to non-invasively provide physicians with detailed, quantitative information (velocity, volume and direction) of blood flow through any particular vessel in the brain. ...

Biosiris

Biosiris is active in the molecular modeling field. It aims to collaborate with pharmaceutical, cosmetic, biotechnological and food companies in developing research activities. Its specificity is the study of structure-activity relationships of proteins and drugs in membranes and water. HistoryBiosiris has been created by one of the reserch centers at the University of Agronomical Sciences in Gemb...

Greenbrook TMS Inc.

Operating through 47 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (TMS), an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with...

Nfocus Neuromedical, Inc.

Nfocus is developing the next generation treatment for brain aneurysms. The company's innovative LUNA(TM) product is a single-deployment, easy-to-use embolization device designed to be a direct replacement to detachable coils. Nfocus is backed by three major U.S. and OUS-based venture funds: DFJ ePlanet Capital, Technology Partners, and InCube Ventures. Other investors include Raffles Capital and ...

Angion Biomedica Corp.

Angion Biomedica is a biopharmaceutical company founded in 1998 focused on discovery and development of drugs that harness the body’s protective, reparative and regenerative systems toward therapeutic benefit. The Company’s fully integrated, multidisciplinary research and development facility is located in Garden City, New York. The Company’s ...

Medtronic Inc.

Medtronic DBS Therapy uses a surgically implanted medical device, similar to a cardiac pacemaker, to deliver carefully controlled electrical stimulation to precisely targeted areas within the brain. The therapy is reversible and can be programmed and adjusted non-invasively (without surgery) by a trained clinician to find the most appropriate type and amount of stimulation for each patient to ...

Allon Therapeutics Inc

Allon Therapeutics Inc. (TSX:NPC) is a Canadian biotechnology company developing drugs that protect against neurodegenerative conditions such as Alzheimer’s disease, mild cognitive impairment, traumatic brain injury, stroke, multiple sclerosis and neuropathy. Allon’s drug discovery platform has resulted in the development of a unique class of peptide compounds that has demonstrated broad effic...

Targepeutics

Targepeutics is a biopharmaceutical company developing selective molecularly targeted therapeutics to fight cancer and other diseases.Our lead compound, Glioblast-13, is currently nearing Phase I clinical trials for high-grade giloma (brain cancer), and is showing promise against other solid tumors.Glioblast-13 is a genetically engineered recombinant protien that specifically binds and destroys ca...

Buyology Inc.

Buyology Inc. (www.buyologyinc.com) is a privately held Marketing Neuroscience firm serving Fortune 100 companies to rigorously measure and manage non conscious decision-making. While our competitors start with a state-of-the-art technology approach, (fMRI, EEG, SST), Buyology Inc. takes a technology-neutral approach to apply the right science to the right problem. Buyology Inc. maintains the worl...

TxCell

TxCell, a spin-off of Inserm (France’s National Institute for Health and Medical Research) is located in the Sophia Antipolis technology park, Nice, France. It is developing innovative personalized cell-based immunotherapies for the treatment of severe chronic inflammatory diseases with high medical need using its unique and proprietary technology platform based on the properties of autolo...

Marina Plastic Surgery Associates

"We were surprised and thrilled to see increases in a variety of areas because it points to a positive change in economic indicators for 2010 - 2011," said Dr. Stevens. "In my own practice, I’ve seen a major increase in demand by men (the study showed an increase overall of 88 percent since 1997), breast lifts and generally a bigger caseload proving that ...

Advanced Biomedical Research Incorporated

Advanced Biomedical Research, Inc. (ABR) Corporate Headquarters is located in Pennington, New Jersey adjacent to the Princeton biopharmaceutical research corridor. ABR is a full service CRO offering an integrated package of customized services including clinical study protocol design, project management and study monitoring, quality assurance auditing, medical safety monitoring, biostatistics and...

PRIMOGENIX

Primogenix was founded early in 2003 with the purpose of providing investigators around the world with access to high quality embryonic stem cells and gene targeting technology in order to further their research efforts. We are dedicated to providing researchers with the tools and technologies necessary to study gene function in animal systems.

The Alzheimer’s Association

The Alzheimer’s Association is the world’s leading voluntary health organization in Alzheimer care, support and research. Its mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Learn more ...

Prana Biotechnology Ltd

Prana’s lead candidate, PBT434, is the first of a new generation of small molecules designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. PBT434 has been shown to reduce abnormal accumulation of α-synuclein and tau proteins in animal models of disease by restoring normal iron balance in the brain. In this way...


More From BioPortfolio on "Positron Emission Tomography (PET) to Study Brain Signaling"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks